Cargando…

Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice

Tuberculosis, caused by infection with Mycobacterium tuberculosis (Mtb), kills over 1.6 million people each year despite availability of antibiotics. The increase in drug resistant Mtb strains is a major public health emergency and host-directed therapy as adjunct to antibiotic treatment has gained...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mortensen, Rasmus, Clemmensen, Helena Strand, Woodworth, Joshua S., Therkelsen, Marie Louise, Mustafa, Tehmina, Tonby, Kristian, Jenum, Synne, Agger, Else Marie, Dyrhol-Riise, Anne Ma, Andersen, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683187/ https://www.ncbi.nlm.nih.gov/pubmed/31396568 http://dx.doi.org/10.1038/s42003-019-0530-3

Ejemplares similares

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
por: Nore, Kristin Grotle, et al.
Publicado: (2020)

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
por: Jenum, Synne, et al.
Publicado: (2021)

Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2021)

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)

A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
por: Chendi, Bih H., et al.
Publicado: (2021)

Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
por: Feruglio, S L, et al.
Publicado: (2015)

The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2016)

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
por: Lieske, Nora V., et al.
Publicado: (2015)

High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis
por: Billeskov, Rolf, et al.
Publicado: (2018)

Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung
por: Woodworth, Joshua S., et al.
Publicado: (2016)

A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin
por: Woodworth, Joshua S., et al.
Publicado: (2021)

Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
por: Trøseid, Marius, et al.
Publicado: (2023)

In vivo antigen expression regulates CD4 T cell differentiation and vaccine efficacy against Mycobacterium tuberculosis infection
por: Clemmensen, Helena Strand, et al.
Publicado: (2021)

In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection
por: Clemmensen, Helena Strand, et al.
Publicado: (2021)

IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting
por: Hoel, Ida Marie, et al.
Publicado: (2019)

DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT
por: Christensen, Erik E., et al.
Publicado: (2022)

Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
por: Prebensen, Christian, et al.
Publicado: (2017)

MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar
por: Jørstad, Melissa Davidsen, et al.
Publicado: (2018)

Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting
por: Jørstad, Melissa Davidsen, et al.
Publicado: (2019)

Mycobacterial antigens in pleural fluid mononuclear cells to diagnose pleural tuberculosis in HIV co-infected patients
por: Mustafa, Tehmina, et al.
Publicado: (2020)

SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
por: Mohn, Kristin G-I, et al.
Publicado: (2023)

Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Diagnosis of extrapulmonary tuberculosis using the MPT64 antigen detection test in a high-income low tuberculosis prevalence setting
por: Hoel, Ida Marie, et al.
Publicado: (2020)

Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young Children
por: Jenum, Synne, et al.
Publicado: (2016)

Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns
por: Christensen, E. E., et al.
Publicado: (2021)

HCV p7 as a novel vaccine-target inducing multifunctional CD4(+) and CD8(+) T-cells targeting liver cells expressing the viral antigen
por: Filskov, Jonathan, et al.
Publicado: (2019)

Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection
por: Clemmensen, Helena Strand, et al.
Publicado: (2020)

Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01
por: Dietrich, Jes, et al.
Publicado: (2014)

Elevated plasma sTIM-3 levels in patients with severe COVID-19
por: Ueland, Thor, et al.
Publicado: (2021)

Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
por: Aamodt, Anne Hege, et al.
Publicado: (2021)

A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8(+) Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice
por: Gram, Gregers Jacob, et al.
Publicado: (2009)

Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2
por: Aid, Saba, et al.
Publicado: (2008)

A 2-Dose AERAS-402 Regimen Boosts CD8(+) Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients
por: Sivakumaran, Dhanasekaran, et al.
Publicado: (2021)

Syringe Free Vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles Provides Strong and Prolonged Protection Against Tuberculosis
por: Christensen, Dennis, et al.
Publicado: (2010)

T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties
por: Lindenstrøm, Thomas, et al.
Publicado: (2017)

Aerosolization of Mycobacterium tuberculosis by Tidal Breathing
por: Dinkele, Ryan, et al.
Publicado: (2020)

Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses
por: Feruglio, Siri L., et al.
Publicado: (2013)

Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results
por: Gran, Gerd, et al.
Publicado: (2013)

Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
por: Wergeland, Ida, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o0goniak4na67il7dgb7gr3or5